Abstract
Purpose
Ectopic fat accumulation plays a significant role in obesity-related metabolic dysfunction, and few studies have reported an association between ectopic gastric fat and metabolic risk factors. We aim to fulfill this need by assessing the degree of gastric submucosal fat accumulation in pathologic sections of 190 sleeve gastrectomy specimens.
Methods
Study patients were divided into two groups (D1 and D2) based on whether fat accumulation exceeded 1/3 of the submucosa of the stomach. Demographic and metabolic risk factors were compared between the two groups. Metabolic risk variables that might be associated with the degree of fat accumulation were screened in the original cohort. After balancing for possible confounders, the robustness of the correlations was assessed using binary and conditional logistic regression analyses.
Results
All study patients had fat accumulation in the submucosa of the stomach. C-reactive protein (CRP), body mass index (BMI), visceral fat area (VFA), and insulin resistance (IR) were higher in the D2 group than in the D1 group in the original cohort (P < 0.05). Logistic regression analysis showed that BMI and IR may be associated with increased fat accumulation. After balancing variables other than obesity indicators and IR using propensity score matching, BMI and IR remained significantly different between the two groups (P < 0.05). Further analysis of the matched cohort using two logistic regression analyses showed that IR was an independent risk factor for increased fat accumulation.
Conclusion
This study indicated that gastric submucosal fat accumulation was prevalent in patients with obesity and was associated with IR.
Graphical Abstract
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The prevalence of overweight and obesity has been increasing globally since 1980 [1]. By 2030, 51% of the population is expected to be obese [2]. Obesity is linked to several chronic illnesses, such as stroke, diabetes, coronary artery disease, hypertension, respiratory diseases, osteoarthritis, and gallstones [3,4,5]. As a result, individuals with obesity have a higher risk of early death and overall mortality rates [6, 7].
Obesity occurs when the body absorbs more calories than it consumes, leading to an abnormal accumulation or distribution of body fat. When the expansion capacity of subcutaneous fat is relatively insufficient to adapt to positive energy balance, fat will deposit in viscera and other ectopic organs [8,9,10,11], such as the liver, pancreas, heart, kidney, and colorectum [12,13,14,15,16]. Increased adiposity in ectopic organs is associated with cardiac and metabolic dysfunction [8, 17]. Therefore, assessing the fat content of different organs has important physiologic and clinical implications.
Fat accumulation in the stomach is considered ectopic and has been described as lipomatosis or lipohyperplasia of the stomach [18, 19]. We speculated that ectopic gastric fat is associated with metabolic risk factors (obesity, hypertension, diabetes, dyslipidemia, insulin resistance). However, there are very few studies on this topic. By assessing the extent of gastric submucosal fat accumulation in pathologic sections of sleeve gastrectomy specimens, we investigated the relationship between fat accumulation and metabolic risk factors to provide some information for studies on the specific role of ectopic fat deposition in the stomach.
Materials and Methods
Study Patients
A total of 190 patients with obesity (median age 32 years, range 15–70 years) who underwent sleeve gastrectomy from August 2020 to September 2022 were included. Exclusion criteria involved incomplete clinical data, serious infectious or immunological diseases, significant gastrointestinal disease, and poorly fixed pathological tissue sections.
Anthropometric and Biochemical Measurements
Standard anthropometric methods were used to measure height and weight after removing shoes and coats. The formula for calculating BMI is as follows: weight (kg) / height2 (m2). After patients had fasted overnight, venous blood samples were taken and sent immediately to the hematology department for total cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), fasting blood glucose (FPG), fasting insulin level (FINS), white blood cell (WBC), and C-reactive protein (CRP) level determination. The formula for calculating homeostasis model assessment of insulin resistance (HOMA-IR) was as follows: fasting blood glucose (mmol/L) × fasting insulin (mU/L) / 22.5 [20].
Measurement of Visceral Fat Area
Dual-energy X-ray absorptiometry (DEXA) is a significant advancement in body fat assessment [21]. It is particularly useful in cases of severe malnutrition and overweight/obesity, as it provides accurate and reliable data on bone and soft tissue composition, including fat mass and lean body mass [22]. In the present study, we used DEXA to measure VFA. Hologic Discovery Wi scanner (S/N 86663) was used to perform the scans.
Evaluation of Fat Accumulation in the Gastric Submucosa
Archived gastric sections stained with hematoxylin and eosin (H&E) were evaluated blindly under a microscope. Compared with the proximal stomach, the distal antrum is thicker and submucosal fat is more common [23, 24], so we selected tissue sections from the antrum for observation. Since there was no grading method for the degree of submucosal fat accumulation in the stomach, we referred to the grading method for hepatic steatosis (0; ≤ 33%; 33–66%; > 66%) [25]. To make it easier to distinguish, we used 1/3 and 2/3 as the cutoffs instead of 33% and 66%. Two pathologists independently assessed the sections. If the assessments of the two pathologists were not in agreement, a third pathologist reviewed the slides and accepted the result that was in accord between the two of them (Fig. 1).
In our study, the degree of gastric fat accumulation was over 0 in all cases, and only one was more than 2/3, so we categorized the patients into a “D1” group (≤ 1/3) and a “D2” group (> 1/3) according to whether the fat accumulation exceeded 1/3 of the gastric submucosa.
Statistical Analysis
Quantitative data were presented as means ± standard deviations (SD) for normal distributions and median (interquartile range) for non-normally distributed variables. Qualitative data were presented as frequencies. Continuous variables were compared using the t-test or Mann–Whitney U test, and categorical variables were compared employing the chi-square test.
Multifactor logistic regression forward stepwise was used to screen out candidate variables associated with degree of fat accumulation in the original cohort. Propensity score matching was used to balance possible confounders. Binary logistic regression and conditional logistic regression were used to analyze the matched data.
SPSS for Windows version 27.0 (SPSS, Chicago, IL, USA) was utilized to conduct the statistical analysis, and a P-value < 0.05 was considered statistically significant.
Results
Demographic and Metabolic Characteristics of Original Cohort
Before propensity score matching, 190 patients who underwent sleeve gastrectomy were included in the study. These patients were categorized into a “D1”group (≤ 1/3) and a “D2” group (> 1/3) according to whether the degree of submucosal fat accumulation in the stomach exceeded 1/3. Age, WBC, TC, TG, HDL, LDL, waist-to-hip ratio (WHR), history of diabetes mellitus, and history of hypertension did not show statistically significant differences between the two groups (P > 0.05). However, the sex ratio was significantly different (P < 0.05), and individuals in D2 group had higher values for CRP, BMI, VFA, and HOMA-IR compared to those in D1 group (P < 0.05) (Table 1).
Univariate and Multivariate Binary Logistic Regression Analyses of Original Cohort
We investigated the relationship between different variables and gastric submucosal fat accumulation using univariate logistic regression analysis, and all variables were subjected to further analysis using multifactorial logistic regression forward stepwise method. The results suggested that BMI and IR might be independent risk factors for fat accumulation in the gastric submucosa (Table 2).
Demographic and Metabolic Characteristics of Matched Cohort
To minimize confounders, a 1:1 propensity score matching analysis was performed with gender, age, CRP, WBC, TC, TG, HDL, LDL, history of hypertension, and history of diabetes as covariates, with a caliper value of 0.01 without replacement.
The analysis included 51 patients from each group (D1 and D2) after propensity score matching. Gender, age, CRP, WBC, lipid levels, history of hypertension, and history of diabetes were not significantly different (P > 0.05) between the two groups.
Compared to pre-matching, VFA no longer showed a statistically significant difference (P > 0.05), but BMI and IR remained significantly higher in the D2 group than in the D1 group (P < 0.05). These results further suggested that BMI and IR might be linked to gastric submucosal fat (Table 3).
Univariate and Multivariate Logistic Regression Analysis of Matched Cohort
To obtain robust results, we used two logistic regression models to analyze the matched data and included variables with P < 0.1 in the univariate analysis into the multivariate regression model. BMI and VFA were adjusted in the binary logistic regression model, and TG, BMI, and VFA were adjusted in the conditional logistic regression model. The results of both models indicated that IR was an independent risk factor for increased fat accumulation in the gastric submucosa (P < 0.05) (Table 4).
Discussion
In conclusion, we found that ectopic fat accumulation in the gastric submucosa was prevalent in patients with obesity. We screened metabolic risk factors related to gastric submucosal fat and found that BMI and IR may be potential related factors. After strict propensity score matching, IR showed a robust correlation with gastric submucosal fat. Although there have been many studies of ectopic fat accumulation in different organs, there are few studies involving ectopic fat accumulation in the stomach. As far as we know, this is the first study to investigate the relationship between gastric submucosal fat and metabolic risks based on pathological histology.
The gastric submucosa has a low amount of adipose tissue under normal conditions. It primarily consists of loose connective tissue with various types of cells, such as fibroblasts, macrophages, mast cells, and adipocytes, as well as blood vessels, lymphatic vessels, and nerve plexuses. Interestingly, pathology reports from bariatric metabolic surgery patients often mention increased submucosal fat in the stomach, leading us to speculate that gastric submucosal fat accumulation may be related to BMI or other obesity indicators. A previous researcher has assessed the degree of gastric wall fat infiltration using CT scans in 120 patients with renal colic and found that it is more common in individuals with a BMI greater than 25 kg/m2 [24]. Another study using similar methods found that gastric wall fat infiltration is more prevalent in overweight individuals, particularly those with increased visceral fat area and percentage of visceral fat [26]. Our study found similar results that fat accumulation in the submucosa of the stomach was prevalent in patients with obesity. Recently, Chumbalkar et al. [27] found that gastric submucosal fat accumulation was associated with BMI by comparing pathologic sections of 128 sleeve gastrectomy specimens with those of 89 Whipple procedure specimens. Although our study of the original cohort found that BMI may be associated with gastric fat accumulation, this correlation was not significant in the multifactorial regression model after rigorous propensity score matching. In the future, we will include more study patients and even people without obesity for in-depth analysis.
Adipose tissue plays a central role in metabolic dysregulation among patients with obesity. Adipocytes function as dynamic endocrine organs and nutritional sensors, strictly regulating the supply of energy. Excessive nutrient supply surpassing adipose tissue’s compensatory capacity leads to adipocyte hypertrophy and the initiation of pathological interactions between adipocytes and macrophages. As a result, adipocytes develop IR and chronically release free fatty acids, which have toxic effects on distant tissues such as the muscle, liver, pancreas, heart, and vascular beds [28]. Recent genetic and biochemical studies have revealed that dysregulation of metabolic mediators released by adipose tissue can lead to IR in other tissues [29]. Therefore, some scholars support the idea that IR is primarily a result of excess body fat [30,31,32]. Although the correlation between ectopic fat and IR has been revealed by an increasing number of studies [33,34,35,36,37,38,39,40,41], there is currently no research on the relationship between fat in the stomach and IR. In the present study, the results of the original and matched cohort showed that gastric submucosal fat accumulation was associated with IR. This finding suggested that the effects of increased gastric submucosal fat on the body may be negative. If increased fat accumulation is found in gastric pathology sections, it should be given attention and described. The specific role of ectopic fat accumulation in the stomach requires further research to elucidate. Our study revealed a potential relationship between gastric submucosal fat and IR, but biological systems are complex and there may be other variables associated with gastric submucosal fat, so further studies are needed to identify and understand these factors. In addition, ectopic fat in different organs is associated with IR, and gastric fat is only a part of ectopic fat pools, so gastric fat can only explain part of IR. To fully understand the relationship between ectopic fat and IR, further investigations are needed to determine how much each ectopic fat organ contributes to IR.
This study has some limitations that should be taken into account. Firstly, based on the cross-sectional design, we can only estimate correlation, not causation. Secondly, the sample size of the study is limited, and we will strive to include more cases in the future and conduct multicenter validation to enhance the generalizability of the findings. Thirdly, the assessment of tissue sections through microscopy is subjective, but efforts were made to minimize potential errors by employing blinded methods during the evaluation process.
Conclusion
Gastric ectopic fat was prevalent in the submucosal layer of patients with obesity, similar to fat accumulation in the liver, and associated with IR. Our observations provide some basis for future studies on the relationship between gastric ectopic fat and metabolic diseases. However, the exact mechanism of gastric ectopic fat deposition and its impact on health remain to be fully elucidated.
Data Availability
The data that support the findings of this study are available upon request.
References
Collaborators GBDO, Afshin A, Forouzanfar MH, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27.
Finkelstein EA, Khavjou OA, Thompson H, et al. Obesity and severe obesity forecasts through 2030. Am J Prev Med. 2012;42(6):563–70.
Kivimaki M, Kuosma E, Ferrie JE, et al. Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe. Lancet Public Health. 2017;2(6):e277–85.
Kivimaki M, Strandberg T, Pentti J, et al. Body-mass index and risk of obesity-related complex multimorbidity: an observational multicohort study. Lancet Diabetes Endocrinol. 2022;10(4):253–63.
Delpino FM, Dos Santos RAP, Petarli GB, et al. Overweight, obesity and risk of multimorbidity: a systematic review and meta-analysis of longitudinal studies. Obes Rev. 2023;24(6): e13562.
Nyberg ST, Batty GD, Pentti J, et al. Obesity and loss of disease-free years owing to major non-communicable diseases: a multicohort study. Lancet Public Health. 2018;3(10):e490–7.
Global BMIMC, Di Angelantonio E, Bhupathiraju ShN, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet. 2016;388(10046):776–86.
Neeland IJ, Poirier P, Despres JP. Cardiovascular and metabolic heterogeneity of obesity: clinical challenges and implications for management. Circulation. 2018;137(13):1391–406.
Szendroedi J, Roden M. Ectopic lipids and organ function. Curr Opin Lipidol. 2009;20(1):50–6.
Piche ME, Tchernof A, Despres JP. Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res. 2020;126(11):1477–500.
Levelt E, Pavlides M, Banerjee R, et al. Ectopic and visceral fat deposition in lean and obese patients with type 2 diabetes. J Am Coll Cardiol. 2016;68(1):53–63.
Graner M, Siren R, Nyman K, et al. Cardiac steatosis associates with visceral obesity in nondiabetic obese men. J Clin Endocrinol Metab. 2013;98(3):1189–97.
Kotronen A, Westerbacka J, Bergholm R, et al. Liver fat in the metabolic syndrome. J Clin Endocrinol Metab. 2007;92(9):3490–7.
Schmitz-Moormann P, Pittner PM, Heinze W. Lipomatosis of the pancreas A morphometrical investigation. Pathol Res Pract. 1981;173(1–2):45–53.
Serra A, Romero R, Lopez D, et al. Renal injury in the extremely obese patients with normal renal function. Kidney Int. 2008;73(8):947–55.
Wada S, Yasunaga Y, Oka K, et al. Submucosal fat accumulation in human colorectal tissue and its association with abdominal obesity and insulin resistance. United Eur Gastroenterol J. 2018;6(7):1065–73.
Britton KA, Fox CS. Ectopic fat depots and cardiovascular disease. Circulation. 2011;124(24):e837–41.
Djuric-Stefanovic A, Ebrahimi K, Sisevic J, et al. Gastroduodenal lipomatosis in familial multiple lipomatosis. Med Princ Pract. 2017;26(2):189–91.
Jeong IH, Maeng YH. Gastric lipomatosis. J Gastric Cancer. 2010;10(4):254–8.
Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.
Cornier MA, Despres JP, Davis N, et al. Assessing adiposity: a scientific statement from the American Heart Association. Circulation. 2011;124(18):1996–2019.
Mazess RB, Barden HS, Bisek JP, et al. Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr. 1990;51(6):1106–12.
Pickhardt PJ, Asher DB. Wall thickening of the gastric antrum as a normal finding: multidetector CT with cadaveric comparison. AJR Am J Roentgenol. 2003;181(4):973–9.
Gervaise A, Naulet P, Gervaise-Henry C, et al. Gastric wall fatty infiltration in patients without overt gastrointestinal disease. AJR Am J Roentgenol. 2016;206(4):734–9.
Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94(9):2467–74.
Kupeli A, Danisan G, Kocak M, et al. Gastric wall fat halo sign in patients without intestinal disease. Clin Imaging. 2019;54:31–6.
Chumbalkar V, Fu Z, Boguniewicz A, et al. Gastric lipohyperplasia presenting as gastric polyposis: the first case report and morphometric study of additional 127 bariatric specimens with a proposal for diagnostic criteria. Obes Surg. 2019;29(6):1805–9.
Cusi K. The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes. Curr Diab Rep. 2010;10(4):306–15.
Li M, Chi X, Wang Y, et al. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct Target Ther. 2022;7(1):216.
Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840–6.
Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med. 2014;371(12):1131–41.
Stinkens R, Goossens GH, Jocken JW, et al. Targeting fatty acid metabolism to improve glucose metabolism. Obes Rev. 2015;16(9):715–57.
Gastaldelli A, Cusi K, Pettiti M, et al. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology. 2007;133(2):496–506.
Lim EL, Hollingsworth KG, Aribisala BS, et al. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011;54(10):2506–14.
Gaborit B, Kober F, Jacquier A, et al. Assessment of epicardial fat volume and myocardial triglyceride content in severely obese subjects: relationship to metabolic profile, cardiac function and visceral fat. Int J Obes (Lond). 2012;36(3):422–30.
Wong VW, Wong GL, Yeung DK, et al. Fatty pancreas, insulin resistance, and beta-cell function: a population study using fat-water magnetic resonance imaging. Am J Gastroenterol. 2014;109(4):589–97.
Czech MP. Insulin action and resistance in obesity and type 2 diabetes. Nat Med. 2017;23(7):804–14.
Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiol Rev. 2018;98(4):2133–223.
Kazankov K, Jorgensen SMD, Thomsen KL, et al. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat Rev Gastroenterol Hepatol. 2019;16(3):145–59.
Iacobellis G. Epicardial adipose tissue in contemporary cardiology. Nat Rev Cardiol. 2022;19(9):593–606.
Petrov MS. Fatty change of the pancreas: the Pandora’s box of pancreatology. Lancet Gastroenterol Hepatol. 2023;8(7):671–82.
Author information
Authors and Affiliations
Contributions
LT conceived the experiments. LT, HX, WY, and XYT carried out the experiments. LT, KJX, ZJL, and SDD analyzed the data. LT and KJX were involved in writing the paper. XLJ revised and improved the manuscript. All authors approved the final manuscript.
Corresponding author
Ethics declarations
Ethics Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study has been approved by the Ethics Committee of the Second Affiliated Hospital of Nanjing Medical University.
Consent to Participate
Since the data was de-identified and was archival in nature, no patient consent was required.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key Points
Gastric submucosal fat accumulation was prevalent in patients with obesity.
Gastric submucosal fat accumulation was associated with IR.
IR was an independent risk factor for increased fat accumulation.
Appendix
Appendix
The general procedures for collection and processing of pathologic sections of the sleeve stomach were as follows:
-
(1)
Specimen fixation: separated sleeve gastrectomy specimens were immediately fixed by formalin immersion.
-
(2)
Tissue collection: four pieces of tissue (cutting edge, fundus, antrum and body) were taken from each sleeve gastrectomy specimen
-
(3)
Tissue fixation: continue to fix the collected tissue with formalin immersion.
-
(4)
Tissue dehydration: the collected tissues were dehydrated to remove the fixative.
-
(5)
Tissue embedding: the processed tissue specimens were embedded in a wax block to form a tissue block.
-
(6)
Section preparation: The tissue block was cut into very thin sections (usually 4–6 microns) using a microtome, and the sections were then placed on slides.
-
(7)
Staining: Hematoxylin and eosin (HE) staining was used to highlight tissue structure and cellular features.
-
(8)
Coverslip encapsulation: The stained slides were covered with coverslips and encapsulated with clear adhesive to protect the sections.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Lu, T., Kan, J., He, X. et al. Gastric Submucosal Fat Accumulation Is Associated with Insulin Resistance in Patients with Obesity. OBES SURG 34, 534–541 (2024). https://doi.org/10.1007/s11695-023-07014-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-023-07014-2